Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma

NCT05830500 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Medullary Thyroid Cancer

Interventions

DRUG: Anlotinib Hydrochloride Capsule

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.